nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—CUBN—Vitamin D (calciferol) metabolism—GC—Graves' disease	0.111	0.209	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism of steroid hormones and vitamin D—GC—Graves' disease	0.0322	0.0606	CbGpPWpGaD
Hydroxocobalamin—CASP9—eye—Graves' disease	0.0221	0.0472	CbGeAlD
Hydroxocobalamin—TCN2—eye—Graves' disease	0.0216	0.0461	CbGeAlD
Hydroxocobalamin—TCN2—connective tissue—Graves' disease	0.0208	0.0444	CbGeAlD
Hydroxocobalamin—CUBN—pituitary gland—Graves' disease	0.0198	0.0423	CbGeAlD
Hydroxocobalamin—CUBN—adipose tissue—Graves' disease	0.0197	0.0421	CbGeAlD
Hydroxocobalamin—MMAA—adipose tissue—Graves' disease	0.0187	0.0398	CbGeAlD
Hydroxocobalamin—MMAB—pituitary gland—Graves' disease	0.0176	0.0375	CbGeAlD
Hydroxocobalamin—MMAB—adipose tissue—Graves' disease	0.0175	0.0373	CbGeAlD
Hydroxocobalamin—CUBN—thyroid gland—Graves' disease	0.0171	0.0364	CbGeAlD
Hydroxocobalamin—MUT—eye—Graves' disease	0.017	0.0362	CbGeAlD
Hydroxocobalamin—MUT—connective tissue—Graves' disease	0.0164	0.0349	CbGeAlD
Hydroxocobalamin—CASP9—adipose tissue—Graves' disease	0.0163	0.0349	CbGeAlD
Hydroxocobalamin—MMAA—thyroid gland—Graves' disease	0.0162	0.0345	CbGeAlD
Hydroxocobalamin—TCN2—pituitary gland—Graves' disease	0.016	0.0342	CbGeAlD
Hydroxocobalamin—TCN2—adipose tissue—Graves' disease	0.016	0.0341	CbGeAlD
Hydroxocobalamin—TCN1—thyroid gland—Graves' disease	0.0154	0.0328	CbGeAlD
Hydroxocobalamin—MMAB—thyroid gland—Graves' disease	0.0151	0.0323	CbGeAlD
Hydroxocobalamin—MTRR—connective tissue—Graves' disease	0.0147	0.0314	CbGeAlD
Hydroxocobalamin—CASP9—thyroid gland—Graves' disease	0.0142	0.0302	CbGeAlD
Hydroxocobalamin—TCN2—thyroid gland—Graves' disease	0.0138	0.0295	CbGeAlD
Hydroxocobalamin—MTR—eye—Graves' disease	0.0133	0.0284	CbGeAlD
Hydroxocobalamin—MTR—connective tissue—Graves' disease	0.0128	0.0274	CbGeAlD
Hydroxocobalamin—MUT—pituitary gland—Graves' disease	0.0126	0.0269	CbGeAlD
Hydroxocobalamin—MUT—adipose tissue—Graves' disease	0.0125	0.0268	CbGeAlD
Hydroxocobalamin—MTRR—pituitary gland—Graves' disease	0.0113	0.0242	CbGeAlD
Hydroxocobalamin—MTRR—adipose tissue—Graves' disease	0.0113	0.0241	CbGeAlD
Hydroxocobalamin—MUT—thyroid gland—Graves' disease	0.0109	0.0232	CbGeAlD
Hydroxocobalamin—MTR—pituitary gland—Graves' disease	0.00988	0.0211	CbGeAlD
Hydroxocobalamin—MTR—adipose tissue—Graves' disease	0.00984	0.021	CbGeAlD
Hydroxocobalamin—MTRR—thyroid gland—Graves' disease	0.00976	0.0208	CbGeAlD
Hydroxocobalamin—MTR—thyroid gland—Graves' disease	0.00851	0.0182	CbGeAlD
Hydroxocobalamin—CASP9—Apoptosis—TNFRSF25—Graves' disease	0.0084	0.0158	CbGpPWpGaD
Hydroxocobalamin—MMAB—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.00837	0.0158	CbGpPWpGaD
Hydroxocobalamin—TCN1—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.00837	0.0158	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis Modulation by HSP70—FASLG—Graves' disease	0.00816	0.0154	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—TNFRSF25—Graves' disease	0.00788	0.0148	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis Modulation by HSP70—FAS—Graves' disease	0.00787	0.0148	CbGpPWpGaD
Hydroxocobalamin—TCN2—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.00779	0.0147	CbGpPWpGaD
Hydroxocobalamin—MUT—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.00662	0.0125	CbGpPWpGaD
Hydroxocobalamin—TCN1—Vitamin B12 Metabolism—IFNG—Graves' disease	0.00637	0.012	CbGpPWpGaD
Hydroxocobalamin—MMAB—Vitamin B12 Metabolism—IFNG—Graves' disease	0.00637	0.012	CbGpPWpGaD
Hydroxocobalamin—CUBN—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.00611	0.0115	CbGpPWpGaD
Hydroxocobalamin—TCN2—Vitamin B12 Metabolism—IFNG—Graves' disease	0.00592	0.0111	CbGpPWpGaD
Hydroxocobalamin—TCN1—Vitamin B12 Metabolism—IL1B—Graves' disease	0.00568	0.0107	CbGpPWpGaD
Hydroxocobalamin—MMAB—Vitamin B12 Metabolism—IL1B—Graves' disease	0.00568	0.0107	CbGpPWpGaD
Hydroxocobalamin—TCN2—Vitamin B12 Metabolism—IL1B—Graves' disease	0.00528	0.00994	CbGpPWpGaD
Hydroxocobalamin—CASP9—HIV-1 Nef: Negative effector of Fas and TNF-alpha—FASLG—Graves' disease	0.00525	0.00987	CbGpPWpGaD
Hydroxocobalamin—CASP9—HIV-1 Nef: Negative effector of Fas and TNF-alpha—FAS—Graves' disease	0.00506	0.00952	CbGpPWpGaD
Hydroxocobalamin—MUT—Vitamin B12 Metabolism—IFNG—Graves' disease	0.00504	0.00948	CbGpPWpGaD
Hydroxocobalamin—MTRR—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.00502	0.00944	CbGpPWpGaD
Hydroxocobalamin—CUBN—Vitamin B12 Metabolism—IFNG—Graves' disease	0.00465	0.00875	CbGpPWpGaD
Hydroxocobalamin—MUT—Vitamin B12 Metabolism—IL1B—Graves' disease	0.00449	0.00846	CbGpPWpGaD
Hydroxocobalamin—CASP9—FAS pathway and Stress induction of HSP regulation—FASLG—Graves' disease	0.00433	0.00814	CbGpPWpGaD
Hydroxocobalamin—CASP9—FAS pathway and Stress induction of HSP regulation—FAS—Graves' disease	0.00417	0.00785	CbGpPWpGaD
Hydroxocobalamin—CUBN—Vitamin B12 Metabolism—IL1B—Graves' disease	0.00415	0.0078	CbGpPWpGaD
Hydroxocobalamin—MMAB—Vitamin B12 Metabolism—TNF—Graves' disease	0.00412	0.00776	CbGpPWpGaD
Hydroxocobalamin—TCN1—Vitamin B12 Metabolism—TNF—Graves' disease	0.00412	0.00776	CbGpPWpGaD
Hydroxocobalamin—MTR—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.00409	0.0077	CbGpPWpGaD
Hydroxocobalamin—MTRR—Folate Metabolism—ICAM1—Graves' disease	0.00408	0.00768	CbGpPWpGaD
Hydroxocobalamin—TCN2—Vitamin B12 Metabolism—TNF—Graves' disease	0.00383	0.00722	CbGpPWpGaD
Hydroxocobalamin—MTRR—Vitamin B12 Metabolism—IFNG—Graves' disease	0.00382	0.00718	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—HLA-E—Graves' disease	0.00375	0.00705	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.00375	0.00705	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.00375	0.00705	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—CD40—Graves' disease	0.00366	0.00689	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—CTLA4—Graves' disease	0.00361	0.00679	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.00357	0.00673	CbGpPWpGaD
Hydroxocobalamin—MTRR—Vitamin B12 Metabolism—IL1B—Graves' disease	0.00341	0.00641	CbGpPWpGaD
Hydroxocobalamin—CASP9—Caspase Cascade in Apoptosis—FASLG—Graves' disease	0.00339	0.00638	CbGpPWpGaD
Hydroxocobalamin—MTR—Folate Metabolism—ICAM1—Graves' disease	0.00333	0.00626	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.0033	0.00621	CbGpPWpGaD
Hydroxocobalamin—CASP9—Caspase Cascade in Apoptosis—FAS—Graves' disease	0.00327	0.00615	CbGpPWpGaD
Hydroxocobalamin—MUT—Vitamin B12 Metabolism—TNF—Graves' disease	0.00326	0.00614	CbGpPWpGaD
Hydroxocobalamin—MTR—Vitamin B12 Metabolism—IFNG—Graves' disease	0.00311	0.00586	CbGpPWpGaD
Hydroxocobalamin—MTRR—Folate Metabolism—IFNG—Graves' disease	0.00311	0.00584	CbGpPWpGaD
Hydroxocobalamin—CUBN—Vitamin B12 Metabolism—TNF—Graves' disease	0.00301	0.00566	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—HLA-DQB1—Graves' disease	0.00297	0.00559	CbGpPWpGaD
Hydroxocobalamin—CASP9—DNA Damage Response—FAS—Graves' disease	0.00284	0.00534	CbGpPWpGaD
Hydroxocobalamin—MTR—Vitamin B12 Metabolism—IL1B—Graves' disease	0.00278	0.00522	CbGpPWpGaD
Hydroxocobalamin—MTRR—Folate Metabolism—IL1B—Graves' disease	0.00277	0.00521	CbGpPWpGaD
Hydroxocobalamin—CASP9—miRNA Regulation of DNA Damage Response—FAS—Graves' disease	0.00274	0.00516	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—HLA-B—Graves' disease	0.00267	0.00503	CbGpPWpGaD
Hydroxocobalamin—MTR—Selenium Micronutrient Network—ICAM1—Graves' disease	0.00264	0.00497	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—FASLG—Graves' disease	0.00261	0.00491	CbGpPWpGaD
Hydroxocobalamin—MTR—Folate Metabolism—IFNG—Graves' disease	0.00253	0.00476	CbGpPWpGaD
Hydroxocobalamin—CASP9—Alzheimers Disease—FAS—Graves' disease	0.00252	0.00474	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—FAS—Graves' disease	0.00252	0.00474	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—IL2RA—Graves' disease	0.0025	0.00471	CbGpPWpGaD
Hydroxocobalamin—CASP9—NOD pathway—IL1B—Graves' disease	0.00249	0.00468	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—FASLG—Graves' disease	0.00249	0.00468	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—HLA-A—Graves' disease	0.00247	0.00466	CbGpPWpGaD
Hydroxocobalamin—MTRR—Vitamin B12 Metabolism—TNF—Graves' disease	0.00247	0.00465	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—FAS—Graves' disease	0.0024	0.00451	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—FASLG—Graves' disease	0.00233	0.00439	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—HLA-DRB1—Graves' disease	0.00226	0.00425	CbGpPWpGaD
Hydroxocobalamin—MTR—Folate Metabolism—IL1B—Graves' disease	0.00226	0.00425	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—FAS—Graves' disease	0.00225	0.00423	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—GC—Graves' disease	0.0022	0.00414	CbGpPWpGaD
Hydroxocobalamin—CASP9—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—Graves' disease	0.00215	0.00404	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—HLA-E—Graves' disease	0.00209	0.00393	CbGpPWpGaD
Hydroxocobalamin—MTR—Vitamin B12 Metabolism—TNF—Graves' disease	0.00201	0.00379	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—GC—Graves' disease	0.00201	0.00379	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—GC—Graves' disease	0.00201	0.00379	CbGpPWpGaD
Hydroxocobalamin—MTR—Selenium Micronutrient Network—IFNG—Graves' disease	0.00201	0.00379	CbGpPWpGaD
Hydroxocobalamin—MTRR—Folate Metabolism—TNF—Graves' disease	0.00201	0.00378	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—B3GNT2—Graves' disease	0.00199	0.00375	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—HLA-E—Graves' disease	0.00197	0.0037	CbGpPWpGaD
Hydroxocobalamin—CASP9—Amyotrophic lateral sclerosis (ALS)—TNF—Graves' disease	0.00192	0.00361	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—GC—Graves' disease	0.00187	0.00352	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—B3GNT2—Graves' disease	0.00182	0.00343	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—B3GNT2—Graves' disease	0.00182	0.00343	CbGpPWpGaD
Hydroxocobalamin—MTR—Selenium Micronutrient Network—IL1B—Graves' disease	0.00179	0.00338	CbGpPWpGaD
Hydroxocobalamin—CASP9—FAS pathway and Stress induction of HSP regulation—TNF—Graves' disease	0.00177	0.00333	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—B3GNT2—Graves' disease	0.00169	0.00319	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—GC—Graves' disease	0.00167	0.00314	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—GC—Graves' disease	0.00167	0.00314	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—B3GNT2—Graves' disease	0.00167	0.00314	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—IFNG—Graves' disease	0.00165	0.00311	CbGpPWpGaD
Hydroxocobalamin—MTR—Folate Metabolism—TNF—Graves' disease	0.00164	0.00308	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—GC—Graves' disease	0.00159	0.003	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—B3GNT2—Graves' disease	0.00153	0.00287	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—B3GNT2—Graves' disease	0.00153	0.00287	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—FASLG—Graves' disease	0.00152	0.00286	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—B3GNT2—Graves' disease	0.00151	0.00284	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—B3GNT2—Graves' disease	0.00151	0.00284	CbGpPWpGaD
Hydroxocobalamin—CASP9—Alzheimers Disease—IL1B—Graves' disease	0.00147	0.00277	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—IL1B—Graves' disease	0.00147	0.00277	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—GC—Graves' disease	0.00147	0.00276	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—FAS—Graves' disease	0.00147	0.00276	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—B3GNT2—Graves' disease	0.00144	0.00271	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—FASLG—Graves' disease	0.00143	0.00269	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—B3GNT2—Graves' disease	0.00142	0.00267	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—HLA-B—Graves' disease	0.0014	0.00264	CbGpPWpGaD
Hydroxocobalamin—CASP9—Caspase Cascade in Apoptosis—TNF—Graves' disease	0.00139	0.00261	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—FAS—Graves' disease	0.00138	0.00259	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—B3GNT2—Graves' disease	0.00133	0.0025	CbGpPWpGaD
Hydroxocobalamin—MTR—Selenium Micronutrient Network—TNF—Graves' disease	0.0013	0.00245	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.00129	0.00242	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—B3GNT2—Graves' disease	0.00126	0.00238	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—B3GNT2—Graves' disease	0.00126	0.00238	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.00124	0.00234	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—B3GNT2—Graves' disease	0.00121	0.00227	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—GC—Graves' disease	0.00121	0.00227	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—B3GNT2—Graves' disease	0.00111	0.0021	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—B3GNT2—Graves' disease	0.00109	0.00205	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—TNF—Graves' disease	0.00107	0.00201	CbGpPWpGaD
Hydroxocobalamin—CASP9—Alzheimers Disease—TNF—Graves' disease	0.00107	0.00201	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TNF—Graves' disease	0.00102	0.00191	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GC—Graves' disease	0.000983	0.00185	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—IFIH1—Graves' disease	0.000971	0.00183	CbGpPWpGaD
Hydroxocobalamin—CASP9—TNF alpha Signaling Pathway—TNF—Graves' disease	0.000946	0.00178	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—B3GNT2—Graves' disease	0.000914	0.00172	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—B3GNT2—Graves' disease	0.00089	0.00167	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—HLA-A—Graves' disease	0.000806	0.00152	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—IL1B—Graves' disease	0.000805	0.00152	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—HLA-E—Graves' disease	0.000764	0.00144	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—B3GNT2—Graves' disease	0.000745	0.0014	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—HLA-A—Graves' disease	0.000737	0.00139	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—HLA-A—Graves' disease	0.000737	0.00139	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HLA-E—Graves' disease	0.000733	0.00138	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CD40—Graves' disease	0.000717	0.00135	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CTLA4—Graves' disease	0.000706	0.00133	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—HLA-A—Graves' disease	0.000686	0.00129	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—B3GNT2—Graves' disease	0.00067	0.00126	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TNF—Graves' disease	0.000623	0.00117	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HLA-A—Graves' disease	0.000611	0.00115	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HLA-A—Graves' disease	0.000611	0.00115	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—TNF—Graves' disease	0.000584	0.0011	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HLA-A—Graves' disease	0.000583	0.0011	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000582	0.00109	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IFIH1—Graves' disease	0.000565	0.00106	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—HLA-B—Graves' disease	0.000544	0.00102	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CD8A—Graves' disease	0.000543	0.00102	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—HLA-A—Graves' disease	0.000538	0.00101	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000527	0.000992	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HLA-B—Graves' disease	0.000523	0.000983	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—CD4—Graves' disease	0.00052	0.000978	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HLA-A—Graves' disease	0.000484	0.000911	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—CD4—Graves' disease	0.000475	0.000894	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—CD4—Graves' disease	0.000475	0.000894	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-E—Graves' disease	0.000445	0.000837	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000442	0.000832	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—CD4—Graves' disease	0.000442	0.000831	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HLA-A—Graves' disease	0.000442	0.000831	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD40—Graves' disease	0.000435	0.000818	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CTLA4—Graves' disease	0.000428	0.000806	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—ICAM1—Graves' disease	0.000425	0.000799	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CD4—Graves' disease	0.000394	0.000741	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CD4—Graves' disease	0.000394	0.000741	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TSHR—Graves' disease	0.000389	0.000732	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CD4—Graves' disease	0.000376	0.000707	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HLA-A—Graves' disease	0.00036	0.000678	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-DQB1—Graves' disease	0.000353	0.000664	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CD4—Graves' disease	0.000347	0.000652	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD8A—Graves' disease	0.000329	0.00062	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CD4—Graves' disease	0.000325	0.000611	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-B—Graves' disease	0.000317	0.000596	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CD4—Graves' disease	0.000312	0.000587	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL2RA—Graves' disease	0.000297	0.000559	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-A—Graves' disease	0.000294	0.000553	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CD4—Graves' disease	0.000285	0.000536	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HLA-A—Graves' disease	0.000271	0.00051	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-DRB1—Graves' disease	0.000268	0.000505	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ICAM1—Graves' disease	0.000258	0.000485	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCL10—Graves' disease	0.000251	0.000473	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CD4—Graves' disease	0.000232	0.000437	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IFNG—Graves' disease	0.000196	0.000369	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL2RA—Graves' disease	0.000192	0.000361	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD4—Graves' disease	0.000189	0.000356	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL1B—Graves' disease	0.000175	0.000329	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CD4—Graves' disease	0.000175	0.000329	CbGpPWpGaD
